Efficacy and safety of perioperative dexmedetomidine in nephrectomy: A systematic review and meta-analysis
Irish Journal of Medical Science (1971 -) · 07.11.2026
DOI: 10.1007/s11845-026-04698-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Irish Journal of Medical Science (1971 -), online erschienen am 07.11.2026. Verfasst von Naglaa Samy Abd El Hady Hammad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lecturer of Critical Care Medicine, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt. Die Arbeit nennt 34 Literaturangaben. Gefördert von: the Deanship of Postgraduate Studies and Scientific Research at Majmaah University.
Abstract (Originalsprache)
BACKGROUND: Dexmedetomidine is a highly selective α2-adrenergic receptor agonist with sedative, analgesic, and sympatholytic effects. The use of dexmedetomidine during nephrectomy has been investigated in several randomized controlled trials, although the findings remain inconsistent. AIMS: This systematic review and meta-analysis evaluate the efficacy and safety of perioperative dexmedetomidine administration in patients undergoing nephrectomy. METHODS: We searched PubMed, Scopus, Web of Science, and Cochrane Library from inception to November 2025. Randomized controlled trials and observational studies comparing dexmedetomidine versus control in patients undergoing nephrectomy were included. Primary outcomes included acute kidney injury (AKI) incidence, renal replacement therapy, Cystatin C, and serum creatinine. Meta-analysis was performed using RevMan software with random-effects models. RESULTS: Eight studies (n = 1140) were included. Systemic intravenous dexmedetomidine did not significantly reduce AKI incidence (RR 1.08, 95% CI [0.85, 1.38]) but significantly reduced postoperative pain scores at day 1 (SMD - 0.37, P < 0.01) and day 2 (SMD - 0.27, P = 0.008), and postoperative nausea and vomiting (RR 0.66, 95% CI [0.44, 0.99]). Regional/neuraxial adjuvant use showed superior analgesia and possible renal-protective effects. CONCLUSION: Dexmedetomidine provides significant analgesic benefits without reducing clinically defined AKI. Its use as a regional adjuvant warrants further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lecturer of Critical Care Medicine, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt.
- School of Nursing, Tennessee State University, Nashville, Tennessee, USA.
- Faculty of Medicine, Sudan International University, Khartoum, Sudan.
- Faculty of Medicine and Health Science, An-Najah National University, Nablus, Palestine.
- Department of Basic Medical Sciences, College of Medicine, Majmaah University, 11952, Majmaah, Saudi Arabia. d.hussain@mu.edu.sa.
Förderung
- the Deanship of Postgraduate Studies and Scientific Research at Majmaah University
Zitieren
APA
Hammad, N. S. A. E. H., Alghzawi, H. M., Eltayb, I. A. E., Ahmad, R. K., & Hussain, S. (2026). Efficacy and safety of perioperative dexmedetomidine in nephrectomy: A systematic review and meta-analysis. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-026-04698-0
Vancouver
Hammad NSAEH, Alghzawi HM, Eltayb IAE, Ahmad RK, Hussain S. Efficacy and safety of perioperative dexmedetomidine in nephrectomy: A systematic review and meta-analysis. Irish Journal of Medical Science (1971 -). 2026. doi:10.1007/s11845-026-04698-0
BibTeX
@article{Hammad2026,
author = {Hammad, Naglaa Samy Abd El Hady and Alghzawi, Hamzah M and Eltayb, Issam Ahmed Elhag and Ahmad, Rasha K and Hussain, Sajid},
title = {Efficacy and safety of perioperative dexmedetomidine in nephrectomy: A systematic review and meta-analysis},
journal = {Irish Journal of Medical Science (1971 -)},
year = {2026},
doi = {10.1007/s11845-026-04698-0}
}
EUVIMED